The global biologics contract development and manufacturing organization (cdmo) market size is estimated to grow by USD 16.32 ...

Grifols S.A. Cl B-0.14% €5.55B Grifols S.A. 0.05% €5.55B ...

Grifols shares tumble after Brookfield drops ... led by e-commerce company Shopify Inc , offset pressure on resource shares due to a stronger U.S. dollar. Ayvens , the car leasing unit of the ...

Mason Capital denuncia ante el regulador español la "falta de transparencia" de Grifols January 13, 2025 Japan Inc’s defensive measures might get help from Uncle Sam. Buyout and credit giant ...

The Michael J. Fox Foundation for Parkinson’s Research has partnered with Grifols, a global healthcare company, to identify ...

Chronos-PD’ is looking for biological signals that could indicate increased chance of developing Parkinson’s disease (PD) years before symptoms ...

Mason Capital Management LLC’s Kenneth M Garschina has called the Spanish regulator’s attention to Grifols SA’s “severe lack of disclosure” as he tries to push for a board reshuffle.

Initiative aims to identify plasma-based biomarkers for early detection Grifols has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to identify plasma-based ...

Grifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF ...

Spanish pharma Grifols is leveraging its massive collection of plasma samples to look for early biomarkers of Parkinson’s disease (PD) thanks to a $21 million grant from the Michael J.

"We urge the CNMV to consider the benefits to all Grifols shareholders from improved disclosure," Mason Capital said. As global markets navigate a mixed economic landscape marked by declining ...